Recombinant TSLP (Tezepelumab Biosimilar) antibody

Catalog No. ABIN7490983

The Human Monoclonal anti-TSLP (Tezepelumab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect TSLP (Tezepelumab Biosimilar) in samples from Human.

Quick Overview for Recombinant TSLP (Tezepelumab Biosimilar) antibody (ABIN7490983)

Target: TSLP (Tezepelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TSLP (Tezepelumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-TSLP (Tezepelumab Biosimilar) Antibody

Purpose: Anti-TSLP (tezepelumab biosimilar) mAb

Characteristics: AMG 157, AMG-157, MEDI-9929, MEDI9929, anti-TSLP-Receptor (TSLP-R, Crl2), tezepelumab-ekko

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG2

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for TSLP (Tezepelumab Biosimilar)

Target: TSLP (Tezepelumab Biosimilar)

Background: Synonyms: Thymic stromal lymphopoietin

UniProt: Q969D9